Key points are not available for this paper at this time.
Ninety-six schizophrenic patients participated in a double-blind, crossover study of the efficacy of trifluoperazine and tranylcypromine therapy alone and in combination. Pseudoneurotic patients had a statistically significant response to tranylcypromine; paranoid (chronic undifferentiated) patients responded best to the combination therapy. The authors urge the use of computer-derived profiles of patients' symptom clusters rather than their diagnoses to ensure selection of the optimum drug therapy.
HEDBERG et al. (Mon,) studied this question.